184 related articles for article (PubMed ID: 16026292)
1. Antihypertensive therapy: role of aldosterone antagonists.
Grandi AM
Curr Pharm Des; 2005; 11(17):2235-42. PubMed ID: 16026292
[TBL] [Abstract][Full Text] [Related]
2. [Aldosterone blockade in essential hypertension].
Venco A; Grandi AM
Ital Heart J; 2005 May; 6 Suppl 1():34S-42S. PubMed ID: 15945298
[TBL] [Abstract][Full Text] [Related]
3. The promise of selective aldosterone receptor antagonists for the treatment of hypertension and congestive heart failure.
Hameedi A; Chadow HL
Curr Hypertens Rep; 2000 Aug; 2(4):378-83. PubMed ID: 10981173
[TBL] [Abstract][Full Text] [Related]
4. Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men's Issue?
Manolis AA; Manolis TA; Melita H; Manolis AS
Curr Hypertens Rep; 2019 Mar; 21(3):22. PubMed ID: 30826898
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone and aldosterone antagonism in systemic hypertension.
Frishman WH; Stier CT
Curr Hypertens Rep; 2004 Jun; 6(3):195-200. PubMed ID: 15128471
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone antagonists in hypertension and heart failure.
Mantero F; Lucarelli G
Ann Endocrinol (Paris); 2000 Feb; 61(1):52-60. PubMed ID: 10790593
[TBL] [Abstract][Full Text] [Related]
7. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
Moore TD; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
[TBL] [Abstract][Full Text] [Related]
8. The role of aldosterone receptor blockade in the management of cardiovascular disease.
Liew D; Krum H
Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone receptor antagonists for hypertension: what do they offer?
Liew D; Krum H
Drugs; 2003; 63(19):1963-72. PubMed ID: 12962513
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease.
Bravo EL
Curr Hypertens Rep; 2003 Apr; 5(2):122-5. PubMed ID: 12642011
[TBL] [Abstract][Full Text] [Related]
11. [The revived interest in aldosterone antagonists].
Waeber B
Rev Med Suisse; 2006 Sep; 2(78):2055-8. PubMed ID: 17019841
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone as a mediator in cardiovascular injury.
Stier CT; Chander PN; Rocha R
Cardiol Rev; 2002; 10(2):97-107. PubMed ID: 11895576
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.
Lyubarova R; Gosmanova EO
Curr Hypertens Rep; 2017 May; 19(5):40. PubMed ID: 28451852
[TBL] [Abstract][Full Text] [Related]
14. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
[TBL] [Abstract][Full Text] [Related]
15. Blocking aldosterone in heart failure.
Shafiq MM; Miller AB
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):379-85. PubMed ID: 19661156
[TBL] [Abstract][Full Text] [Related]
16. Eplerenone: cardiovascular protection.
Brown NJ
Circulation; 2003 May; 107(19):2512-8. PubMed ID: 12756192
[TBL] [Abstract][Full Text] [Related]
17. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
[TBL] [Abstract][Full Text] [Related]
18. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data.
Black HR
Am Heart J; 2004 Apr; 147(4):564-72. PubMed ID: 15077068
[TBL] [Abstract][Full Text] [Related]
19. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
20. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.
Lim PO; Jung RT; MacDonald TM
Br J Clin Pharmacol; 1999 Nov; 48(5):756-60. PubMed ID: 10594479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
